CMX Research Inc.
416 North Service Road East, Suite 2
Oakville, ON L6H 5R2
CMX Research Inc. is a Site Management Organization (SMO), professionally and effectively conducting pharmaceutical, biotech and medical device research at our 50 sites in Canada. Our Services cover a broad range of study conduct activities that meet FDA, HPB and ICH standards. Our research efforts are segmented into clinical specialties to better serve our clients. Our commitment is to ethically, effectively and efficiently conduct medical research.
At CMX Research, we set our sights high. We know that our clients’ success depends on accurate and reliable data. We understand that you need a responsive clinical team, experienced in pharmaceutical, medical device and biotech studies.
We recognize the importance of a good enrollment rate and an interested, compliant patient population, drawn from a diversified demographic area. We recognize that time is of the essence in the work we do and we pride ourselves with our track record in patient recruitment and compliance.
CMX Research Inc. delivers the excellence you demand.
Our clinical specialties include:
CMX Research Inc. is proud to be able to share the list of our clients. These organizations represent many of the world's largest pharmaceutical, biotech, medical device and contract research companies.
Contract Research Organizations
Each of the CMX Research sites is integrated into our investigators’ clinical practices. As such, they offer an attractive setting, close to public transport. Each site has been selected to ensure ready access to clinical laboratory and diagnostic imaging capabilities as well as other equipment relevant to their particular specialties. All sites also understand that, as partners in clinical development with our sponsors, we are part of a team and we pride ourselves in working in a professional and courteous manner.
CMX Research INC.
NETWORK SITES - GENERAL PRACTITIONERS = 10
NETWORK SITES - UROLOGY = 35
We are also closely affiliated with P.I.’s in the following therapeutic areas:
Richard Casey, M.D., F.R.C.S. (C)
CEO, CMX Research Inc.
Dr. Casey is the Chairman and CEO of CMX Research Inc. and the Medical Director of Fe/Male Health Centres, a treatment network offering comprehensive services in sexual medicine and prostate disorders for men. He and his professional team have participated in numerous clinical research trials and have extended their organization to include a variety of medical specialties. Dr. Casey contributes his considerable expertise and a progressive leadership style to the on-going research effort in medical therapeutics. He determines the strategy and operating plans of CMX Research Inc. as well as implements and tracks business development initiatives. He assists with study protocol, feasibility questionnaires, budget negotiations and finalizes contracts with sponsors. Furthermore, he sets corporate goals and the strategic direction for CMX Research Inc. in conjunction with the President, the VP of Corporate Development and the VP of Clinical Services.
CMX Research sites draw patients from both our investigators own clinical practices and the local surrounding populations. Currently our total site direct patient population exceeds 200,000 with an additional 3.5 million patients within 20 miles of our sites. Canada has a tremendously varied ethic background in our population and we can offer a truly homogeneous pool of participants to draw from.
We will deliver quality service that goes beyond expectations.
In a world of global enterprise, we know that time wasted is money lost. At CMX Research, we understand the value of saving time, effort and expense. We recognize that quality performance, responsive service and flexible options for a competitive price are expected.
CMX Research delivers a full range of cost-effective facilities and services.
We commit to:
We have built the CMX Research network on a foundation of professionalism. We ensure that each of our sites is supervised by a committed Principal Investigator, Study Coordinator and further supported by an experienced clinical team.
We are continuously refining our Standard Operating Procedures to reflect exacting expectations in meeting regulatory requirements of HPB, FDA and ICH.
CMX Research Inc. is committed to:
We maintain a deep conviction that personal service is essential to a quality program. We provide a full-time research coordinator to facilitate each study and our investigative physicians work actively within the CMX Research network. Dr. Richard Casey, President and Medical Director, makes himself readily available to respond to issues arising at any of the research sites. We pride ourselves on the courteous welcome that we offer CRAs and we provide them with comfortable office accommodations. You can depend on our full support at every stage of all research projects.